142 related articles for article (PubMed ID: 20714290)
1. Antiplatelet aggregation and platelet activating factor (PAF) receptor antagonistic activities of the essential oils of five Goniothalamus species.
Moharam BA; Jantan I; Ahmad Fb; Jalil J
Molecules; 2010 Jul; 15(8):5124-38. PubMed ID: 20714290
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of compounds from Goniothalamus tapis Miq. and Goniothalamus uvaroides King on platelet-activating factor receptor binding.
Moharam BA; Jantan I; Jalil J; Ahmad F
Phytother Res; 2012 May; 26(5):687-91. PubMed ID: 22002630
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor (PAF) antagonistic activity of a new biflavonoid from Garcinia nervosa var. pubescens King.
Jalil J; Jantan I; Ghani AA; Murad S
Molecules; 2012 Sep; 17(9):10893-901. PubMed ID: 22964504
[TBL] [Abstract][Full Text] [Related]
4. A comparative analysis of essential oils of Goniothalamus macrocalyx Ban., Goniothalamus albiflorus Ban. and Goniothalamus tamirensis Pierre ex Fin. & Gagnep. from Vietnam.
Thang TD; Huong LT; Dai DN; Ogunwande IA
Nat Prod Res; 2013; 27(21):1999-2005. PubMed ID: 23822670
[TBL] [Abstract][Full Text] [Related]
5. Chemical characterization of Goniothalamus macrophyllus and Goniothalamus malayanus leaves' essential oils.
Shakri NM; Salleh WMNHW; Khamis S; Mohamad Ali NA
Z Naturforsch C J Biosci; 2020 Nov; 75(11-12):485-488. PubMed ID: 32966236
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor (PAF) receptor-binding antagonist activity of Malaysian medicinal plants.
Jantan I; Rafi IA; Jalil J
Phytomedicine; 2005 Jan; 12(1-2):88-92. PubMed ID: 15693713
[TBL] [Abstract][Full Text] [Related]
7. The Synergistic Effect of
Ke J; Li MT; Huo YJ; Cheng YQ; Guo SF; Wu Y; Zhang L; Ma J; Liu AJ; Han Y
Drug Des Devel Ther; 2021; 15():3543-3560. PubMed ID: 34429584
[TBL] [Abstract][Full Text] [Related]
8. Bakkenolide G, a natural PAF-receptor antagonist.
Liao CH; Ko FN; Wu TS; Teng CM
J Pharm Pharmacol; 1997 Dec; 49(12):1248-53. PubMed ID: 9466352
[TBL] [Abstract][Full Text] [Related]
9. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
[TBL] [Abstract][Full Text] [Related]
10. Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin.
Hsu HC; Yang WC; Tsai WJ; Chen CC; Huang HY; Tsai YC
Biochem Biophys Res Commun; 2006 Jul; 345(3):1033-8. PubMed ID: 16712790
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
Ammit AJ; O'Neill C
Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
[TBL] [Abstract][Full Text] [Related]
12. [Antagonistic effect of hydroxysafflor yellow A on the platelet activating factor receptor].
Zang BX; Jin M; Si N; Zhang Y; Wu W; Piao YZ
Yao Xue Xue Bao; 2002 Sep; 37(9):696-9. PubMed ID: 12567893
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of phylligenin and quebrachitol isolated from Mitrephora vulpina on platelet activating factor receptor binding and platelet aggregation.
Moharam BA; Jantan I; Jalil J; Shaari K
Molecules; 2010 Nov; 15(11):7840-8. PubMed ID: 21060292
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor (PAF) receptor binding antagonist activity of the methanol extracts and isolated flavonoids from Chromolaena odorata (L.) King and Robinson.
Ling SK; Pisar MM; Man S
Biol Pharm Bull; 2007 Jun; 30(6):1150-2. PubMed ID: 17541171
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum.
Nordin N; Jalil J; Jantan I; Murad S
Pharm Biol; 2012 Mar; 50(3):284-90. PubMed ID: 22103812
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
[TBL] [Abstract][Full Text] [Related]
17. An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding.
Mikashima H; Takehara S; Muramoto Y; Khomaru T; Terasawa M; Tahara T; Maruyama Y
Jpn J Pharmacol; 1987 Aug; 44(4):387-91. PubMed ID: 2890779
[TBL] [Abstract][Full Text] [Related]
18. Effects of antiplatelet agents on platelet aggregation induced by platelet--activating factor (PAF) in human whole blood.
Chan WP; Levy JV
Prostaglandins; 1991 Oct; 42(4):337-42. PubMed ID: 1665568
[TBL] [Abstract][Full Text] [Related]
19. Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: binding and in vitro functional studies.
Castro-Faria-Neto HC; Bozza PT; Cruz HN; Silva CL; Violante FA; Barbosa-Filho JM; Thomas G; Martins MA; Tibiriçá EV; Noel F
Planta Med; 1995 Apr; 61(2):101-5. PubMed ID: 7753913
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of acetylmelodorinol, chrysin and polycarpol from Mitrella kentii on prostaglandin E₂ and Thromboxane B₂ production and platelet activating factor receptor binding.
Saadawi S; Jalil J; Jasamai M; Jantan I
Molecules; 2012 Apr; 17(5):4824-35. PubMed ID: 22538486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
